[Federal Register Volume 59, Number 2 (Tuesday, January 4, 1994)]
[Notices]
[Page 333]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-108]


[[Page Unknown]]

[Federal Register: January 4, 1994]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

 

Controlled Substances; Established 1993 Aggregate Production 
Quotas

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Final rule establishing 1993 aggregate production quotas.

-----------------------------------------------------------------------

SUMMARY: The interim rule (58 FR 51382, October 1, 1993) which 
established 1993 revised aggregate production quotas for some 
controlled substances in Schedules I and II, as required under the 
Controlled Substances Act (CSA) (21 U.S.C. 826) is adopted without 
change.

EFFECTIVE DATE: January 4, 1994.

FOR FURTHER INFORMATION CONTACT:
Howard McClain, Jr., Chief, Drug & Chemical Evaluation Section, Drug 
Enforcement Administration, Washington, DC 20537, telephone: (202) 307-
7183.

SUPPLEMENTARY INFORMATION: Section 306 of the Controlled Substances 
Act, (21 U.S.C. 826), requires the Attorney General to establish 
aggregate production quotas for controlled substances in Schedules I 
and II each year. This responsibility has been delegated to the 
Administrator of the Drug Enforcement Administration pursuant to 
Sec. 0.100 of title 28 of the Code of Federal Regulations.
    On October 1, 1993, an interim rule establishing revised 1993 
aggregate production quotas for controlled substances in Schedules I 
and II was published in the Federal Register (58 FR 51382). One comment 
was received from a company supporting the use of the interim rule in 
establishing aggregate production quotas under certain circumstances. 
The interim rule is adopted without change.
    This rule is not a significant regulatory action and therefore has 
not been reviewed by the Office of Management and Budget pursuant to 
Executive Order 12866.
    These actions have been analyzed in accordance with the principles 
and criteria contained in Executive Order 12612, and it has been 
determined that this matter does not have sufficient federalism 
implications to warrant the preparation of a Federalism Assessment.
    The Administrator hereby certifies that this action will have no 
significant impact upon small entities whose interests must be 
considered under the Regulatory Flexibility Act, 5 U.S.C. 601, et seq. 
The establishment of annual aggregate production quotas for Schedules I 
and II controlled substances is mandated by law and by international 
commitments of the United States. Such quotas impact predominantly upon 
major manufacturers of the affected controlled substance.
    Therefore, under the authority vested in the Attorney General by 
section 306 of the CSA of 1970 (21 U.S.C. 826) and delegated to the 
Administrator by Sec. 0.100 of title 28 of the Code of Federal 
Regulations, the Administrator of the DEA hereby establishes the 
following revised 1993 aggregate production quotas for the listed 
controlled substances, expressed in grams of anhydrous base:

------------------------------------------------------------------------
                                                             Established
                       Basic class                           1993 quotas
                                                             (in grams) 
------------------------------------------------------------------------
Schedule I:                                                             
  Methaqualone............................................            12
  3,4-Methylenedioxyamphetamine...........................            12
  3,4-Methylenedioxymethamphetamine.......................            12
Schedule II:                                                            
  Dextropropoxyphene......................................   115,162,000
  Methadone (for sale)....................................     3,675,000
  Methadone Intermediate (for conv).......................     4,598,000
  Oxycodone (for sale)....................................     3,520,000
  Phencyclidine...........................................            54
  Thebaine................................................     7,795,000
------------------------------------------------------------------------


    Dated: December 22, 1993.
Stephen H. Greene,
Acting Administrator of Drug Enforcement.
[FR Doc. 94-108 Filed 1-3-94; 8:45 am]
BILLING CODE 4410-09-M